|
|
|
Volumn 23, Issue 1 SUPPL. 2, 1996, Pages 60-67
|
|
High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
CARMUSTINE;
CD34 ANTIGEN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
GROWTH FACTOR;
METHOTREXATE;
PACLITAXEL;
BONE MARROW TRANSPLANTATION;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG MEGADOSE;
HEMATOPOIETIC STEM CELL;
HIGH RISK POPULATION;
HUMAN;
LYMPH NODE METASTASIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
ACTUARIAL ANALYSIS;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE II;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
LYMPHATIC METASTASIS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PROGNOSIS;
PROSPECTIVE STUDIES;
RANDOMIZED CONTROLLED TRIALS;
REMISSION INDUCTION;
|
|
EID: 0029915944
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (17)
|
|
References (0)
|
